Received Aug 27, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| UNK | VACCINE NOT SPECIFIED (NO BRAND NAME) | UNKNOWN MANUFACTURER | UNK | Y008282 | — |
| VARCEL | VARICELLA (VARIVAX) | MERCK & CO. INC. | UNK | X023323 | — |
No additional AEs were reported; Medical assistant reported that a patient received two doses of VARIVAX on the same day. First dose was (lot y008282, exp 10/21/2025) and second dose was (lot x023323, exp 9/20/2025). No additional AEs were reported, no further information provi; This spontaneous report was received from a medical assistant and refers to a patient of unknown age and gender. The patient's medical history, concurrent conditions and concomitant therapies were not reported. On 01-AUG-2025, the patient was vaccinated with the first dose of Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live (PROQUAD), (valid lot #Y008282, expiration date: 21-Oct-2025) for prophylaxis. The vaccine was reconscitiuted with sterile diluent (lot # and expiration date was not provided). On 01-AUG-2025, the patient was vaccinated with the first dose of Varicella Virus Vaccine Live (Oka-Merck) (VARIVAX), (lot #X023323, expiration date: 20-Sep-2025) for prophylaxis. The vaccine was reconscitiuted with sterile diluent (lot # and expiration date was not provided) (overdose). No additional adverse events (AEs) were reported. This case was considered as invalid due to lack of patient's identifiers.
sterile diluent